SandboxAlonso: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Labetalol}} | ||
{{CMG}}; {{AE}} {{SS}} | {{CMG}}; {{AE}} {{SS}} | ||
'''''For patient information about | '''''For patient information about Labetalol oral, click [[Labetalol (patient information)|here]]''''' | ||
{{SB}} | {{SB}} TRANDATE<sup>®</sup>(discontinued)NORMOZIDE<sup>®</sup>(discontinued)NORMODYNE<sup>®</sup>(discontinued) | ||
==Overview== | ==Overview== | ||
'''Labetalol''' ('''Normodyne''', '''Trandate''', fixed combination with [[hydrochlorothiazide]]: '''Normozyde''') is an [[alpha blocker|alpha-1]] and[[beta blocker|beta adrenergic blocker]] used to treat [[hypertension|high blood pressure]]. It works by blocking these adrenergic receptors, which slows sinus [[heart]] rate, decreases peripheral vascular resistance. | |||
It has a particular indication in the treatment of [[pregnancy-induced hypertension]]. | |||
==Category== | ==Category== | ||
Cardiovascular Drugs:Beta blockers | |||
==FDA Package Insert== | |||
===Labetalol Hydrochloride injection=== | |||
'''| [[Labetalol injection indications and usage|Indications and Usage]]''' | |||
'''| [[Labetalol injection dosage and administration|Dosage and Administration]]''' | |||
'''| [[Labetalol injection dosage forms and strengths|Dosage Forms and Strengths]]''' | |||
'''| [[Labetalol injection contraindications|Contraindications]]''' | |||
'''| [[Labetalol injection warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Labetalol injection adverse reactions|Adverse Reactions]]''' | |||
'''| [[Labetalol injection drug interactions|Drug Interactions]]''' | |||
'''| [[Labetalol injection use in specific populations|Use in Specific Populations]]''' | |||
'''| [[Labetalol injection overdosage|Overdosage]]''' | |||
'''| [[Labetalol injection description|Description]]''' | |||
'''| [[Labetalol injection clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Labetalol injection nonclinical toxicology|Nonclinical Toxicology]]''' | |||
'''| [[Labetalol injection how supplied storage and handling|How Supplied/Storage and Handling]]''' | |||
'''| [[Labetalol injection patient counseling information|Patient Counseling Information]]''' | |||
'''| [[Labetalol injection labels and packages|Labels and Packages]]''' | |||
== | ===Labetalol Hydrochloride tablet=== | ||
''' | '''| [[Labetalol tablet indications and usage|Indications and Usage]]''' | ||
'''| [[ | '''| [[Labetalol tablet dosage and administration|Dosage and Administration]]''' | ||
'''| [[ | '''| [[Labetalol tablet dosage forms and strengths|Dosage Forms and Strengths]]''' | ||
'''| [[ | '''| [[Labetalol tablet contraindications|Contraindications]]''' | ||
'''| [[ | '''| [[Labetalol tablet warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[ | '''| [[Labetalol tablet adverse reactions|Adverse Reactions]]''' | ||
'''| [[ | '''| [[Labetalol tablet drug interactions|Drug Interactions]]''' | ||
'''| [[ | '''| [[Labetalol tablet use in specific populations|Use in Specific Populations]]''' | ||
'''| [[ | '''| [[Labetalol tablet overdosage|Overdosage]]''' | ||
'''| [[ | '''| [[Labetalol tablet description|Description]]''' | ||
'''| [[ | '''| [[Labetalol tablet clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[ | '''| [[Labetalol tablet nonclinical toxicology|Nonclinical Toxicology]]''' | ||
'''| [[Labetalol tablet how supplied storage and handling|How Supplied/Storage and Handling]]''' | |||
'''| [[ | '''| [[Labetalol tablet patient counseling information|Patient Counseling Information]]''' | ||
'''| [[ | '''| [[Labetalol tablet labels and packages|Labels and Packages]]''' | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
The mechanism of action of the [[antihypertensive]] response of Labetalol has not been definitively established. Possible factors that may be involved include: (1) decreased heart rate, (2) decreased myocardial contractility, (3) diminution of tonic sympathetic outflow to the periphery from cerebral vasomotor centers, (4) suppression of renin activity and (5) vasodilation and decreased peripheral vascular resistance. | |||
The mechanism of action of | |||
==References== | ==References== | ||
Line 48: | Line 59: | ||
[[Category:Beta blockers]] | [[Category:Beta blockers]] | ||
[[Category:Cardiovascular Drugs]] | [[Category:Cardiovascular Drugs]] | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} |
Revision as of 15:06, 11 July 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
For patient information about Labetalol oral, click here
Synonyms / Brand Names: TRANDATE®(discontinued)NORMOZIDE®(discontinued)NORMODYNE®(discontinued)
Overview
Labetalol (Normodyne, Trandate, fixed combination with hydrochlorothiazide: Normozyde) is an alpha-1 andbeta adrenergic blocker used to treat high blood pressure. It works by blocking these adrenergic receptors, which slows sinus heart rate, decreases peripheral vascular resistance.
It has a particular indication in the treatment of pregnancy-induced hypertension.
Category
Cardiovascular Drugs:Beta blockers
FDA Package Insert
Labetalol Hydrochloride injection
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Labetalol Hydrochloride tablet
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
The mechanism of action of the antihypertensive response of Labetalol has not been definitively established. Possible factors that may be involved include: (1) decreased heart rate, (2) decreased myocardial contractility, (3) diminution of tonic sympathetic outflow to the periphery from cerebral vasomotor centers, (4) suppression of renin activity and (5) vasodilation and decreased peripheral vascular resistance.